Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze LQDA Liquidia Corporation. Please read: https://finlab.finance/en/setup?stock=LQDA

No install, open FinLab Studio

LQDA

Liquidia Corporation Healthcare As of 2026-07-31 Updated daily after market close

steady quality, premium valuation.

2 active signals
Top-quintile 6-month momentum Filed revenue acceleration
This page refreshes daily after the close. Add Liquidia Corporation to your watchlist to track signal changes on your next visit.
Valuation 17Quality 73Growth 57Momentum 98Risk / liquidity 55

Is Liquidia Corporation a buy? Fundamentals and valuation first

  • Quality is above average. Operating margin sits near the 68th percentile. TTM ROE is about 20.5%.

  • Valuation is expensive. TTM P/E is in the 99th percentile, above most peers.

  • Recent volatility is elevated. 60-day annualized volatility is in the 78th percentile. Average 20-day dollar volume is about $115.6M.

  • Signals are active now. Top-quintile 6-month momentum, Filed revenue acceleration currently holds; the tables below show what followed in this stock’s own history.

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 96.59574468085106%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

21 historical occurrences (since 2019-01-28)
Average forward return after Top-quintile 6-month momentum。20-day: Win 47.6%, Sample 21, Median -0.78%, Excess +6.24%, Beat mkt rate 52.4%；60-day: Win 71.4%, Sample 21, Median +8.72%, Excess +15.9%, Beat mkt rate 66.7%；120-day: Win 65%, Sample 20, Median +17.33%, Excess +16.58%, Beat mkt rate 60%

120 days after: historical avg +23.34%

20-day +6.14%
60-day +18.51%
120-day +23.34%
20-day
60-day
120-day
Win
47.6%
71.4%
65%
Sample
21
21
20
Median
-0.78%
+8.72%
+17.33%
Excess
+6.24%
+15.9%
+16.58%
Beat mkt rate
52.4%
66.7%
60%

Over 20 occurrences, 120-day forward avg gained 23.34%, beat the market by 16.58 pts; win rate 65%.

Filed revenue acceleration

Active · now 1936.658653846154%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

12 historical occurrences (since 2019-08-14)
Average forward return after Filed revenue acceleration。20-day: Win 83.3%, Sample 12, Median +11.63%, Excess +8.03%, Beat mkt rate 83.3%；60-day: Win 72.7%, Sample 11, Median +48.39%, Excess +28.2%, Beat mkt rate 63.6%；120-day: Win 80%, Sample 10, Median +60.4%, Excess +37.39%, Beat mkt rate 60%

120 days after: historical avg +48.08%

20-day +11.59%
60-day +37.94%
120-day +48.08%
20-day
60-day
120-day
Win
83.3%
72.7%
80%
Sample
12
11
10
Median
+11.63%
+48.39%
+60.4%
Excess
+8.03%
+28.2%
+37.39%
Beat mkt rate
83.3%
63.6%
60%

Over 10 occurrences, 120-day forward avg gained 48.08%, beat the market by 37.39 pts; win rate 80%.

Market-wide momentum baseline

Across 97,878 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.26%, a 58.3% positive-return rate, and +2.90 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

13 times historically; 60-day forward avg -4.03%, win rate 50%, beating the market by -4.56 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

9 times historically; 60-day forward avg +22.03%, win rate 62.5%, beating the market by +18.13 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.